Kamada jumps on $50m source plasma deal Globes – Israel Business NewsKamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies Yahoo FinanceKamada (KMDA) Secures $50M Plasma Supply Agreement GuruFocusKamada Ltd. (NASDAQ: KMDA) signs three-year $50M plasma supply agreement Stock TitanKamada secures $50M plasma supply deal over three years Investing.com
